Literature DB >> 18987608

Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?

Jana Kopincova1, Angelika Puzserova, Iveta Bernatova.   

Abstract

OBJECTIVES: The effect of 8-week-lasting low-dose treatment of NG-Nitro-L-arginine methyl ester (L-NAME), a nitric oxide (NO) synthase inhibitor, was investigated in borderline hypertensive rats (BHR) to examine, whether dose of 1.5 mg/kg/day affects feedback regulation of NO synthesis.
METHODS: Blood pressure (BP) of 12 weeks old Wistar and BHR rats was determined non-invasively by tail-cuff. NO synthase (NOS) activity was determined by conversion of [3H]-L-arginine to [3H]-L-citrulline in the aorta, left ventricle (LV) and hypothalamus. Vascular function of the femoral artery was determined using Mulvany's myograph in isometric conditions.
RESULTS: Chronic low-dose L-NAME treatment of BHR induced sustained blood pressure elevation and left ventricular hypertrophy associated with the decrease in NOS activity in left ventricle and unaltered NOS activity in the aorta. By contrast, the improvement of LV and aortic NOS activity was found in Wistar rats. In hypothalamus, no changes in NOS activity were found in both BHR and Wistar. In Wistar, acetylcholine-induced relaxation of the femoral artery was increased and serotonin-induced and noradrenalin-induced constriction were reduced in L-NAME treated group. These effects, however, were not seen in BHR.
CONCLUSION: The results indicate that NOS/NO feedback regulation works differently under conditions of normotension and prehypertension. Low-dose L-NAME treatment accentuated NO production in normotensive rats, but it failed to improve NOS activity in BHR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987608

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

1.  Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats.

Authors:  Jana Radosinska; Barbara Bacova; Iveta Bernatova; Jana Navarova; Anna Zhukovska; Angela Shysh; Ludmila Okruhlicova; Narcis Tribulova
Journal:  Mol Cell Biochem       Date:  2010-10-21       Impact factor: 3.396

2.  Biochemical aspects of nitric oxide synthase feedback regulation by nitric oxide.

Authors:  Jana Kopincová; Angelika Púzserová; Iveta Bernátová
Journal:  Interdiscip Toxicol       Date:  2011-06

3.  Effects of PPAR γ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats.

Authors:  Ima Dovinová; Miroslav Barancik; Miroslava Majzunova; Stefan Zorad; Lucia Gajdosechová; Linda Gresová; Sona Cacanyiova; Frantisek Kristek; Peter Balis; Julie Y H Chan
Journal:  PPAR Res       Date:  2013-12-19       Impact factor: 4.964

4.  Endothelium-dependent vasodilation effects of Panax notoginseng and its main components are mediated by nitric oxide and cyclooxygenase pathways.

Authors:  Yanyan Wang; Yu Ren; Leilei Xing; Xiangdong Dai; Sheng Liu; Bin Yu; Yi Wang
Journal:  Exp Ther Med       Date:  2016-11-09       Impact factor: 2.447

5.  L-NAME releases nitric oxide and potentiates subsequent nitroglycerin-mediated vasodilation.

Authors:  Taiming Liu; Meijuan Zhang; George T Mukosera; Dan Borchardt; Qian Li; Trent E Tipple; Abu Shufian Ishtiaq Ahmed; Gordon G Power; Arlin B Blood
Journal:  Redox Biol       Date:  2019-06-04       Impact factor: 11.799

Review 6.  Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence?

Authors:  Iveta Bernatova
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.